Turn defense budgets, aviation trends, and procurement data into focused market strategies.
Fortune Business Insights™ aims to deliver curated reports on the aviation industry to its large base of valuable clients. each report is developed as per the requirements of the clients and they contain almost every aspect of the given market.The aviation industry plays a significant role in shaping the viability of the economy worldwide. It consists of three main components, namely, military, general, and commercial. Airlines for America, a renowned trade organization stated that in the U.S., commercial aviation aids in propelling more than USD 1.5 trillion every year in terms of economic activities and creates more than 11 million jobs. The subsectors of this industry house the finance, marketing, maintenance, and operations divisions. Since the past few decades, the global economy has improved. Thus, the industry has matured by employing better cost controls and capacity management. It has also grown in profitability and have benefitted from the upsurging demand for passenger air travel. Engine and airframe manufacturers have reported record delivers and booked multiple orders. Also, the banks are getting very eager to lend even though the new capital regulations are hovering above them with several constraints. Our reports will help the clients in gaining complete insights into each market that come under the aviation industry.
The global commercial aircraft in-seat power system market size is projected to grow from $894.9 million in 2026 to $1,810.5 million by 2034... Read More
The aerospace NDI market size is projected to grow from $2.39 billion in 2026 to $4.39 billion by 2034, exhibiting a CAGR of 7.9%... Read More
The global avionics market size is projected to grow from $32.50 billion in 2026 to $70.67 billion by 2034, at a CAGR of 10.20% during the forecast period... Read More
The global aircraft overhead stowage bins market size is projected to grow from $1.08 billion in 2026 to $3.98 billion by 2034... Read More
The global enhanced vision system market size is projected to grow from $2.77 billion in 2026 to $6.32 billion by 2034, at a CAGR of 10.86%... Read More
The global aerospace fiber optic sensors market size is projected to grow from $1.44 billion in 2026 to $2.94 billion by 2034, at CAGR of 9.33%... Read More
The aerospace oxygen system market size is projected to grow from $3.43 billion in 2026 to $5.71 billion by 2034, exhibiting a CAGR of 6.6%... Read More
The global aerospace testing, inspection, and certification market size is projected to grow from $13.70 billion in 2026 to $22.46 billion by 2034... Read More
The global aircraft electric taxiing system market size is projected to grow from $89.2 million in 2026 to $425.2 million by 2034, at a CAGR of 21.6%... Read More
The cabin crew training market size is projected to grow from $921.0 million in 2026 to $1,640.6 million by 2034, at a CAGR of 7.5% during the forecast period... Read More
The global aviation tooling market size is projected to grow from $5.55 billion in 2026 to $9.02 billion by 2034, exhibiting a CAGR of 6.3%... Read More
The global helicopter market size is projected to grow from $50.02 billion in 2026 to $65.53 billion by 2034, at a CAGR of 3.44% during the forecast period... Read More
The global aviation maintenance training market size is projected to grow from $5.37 billion in 2026 to $12.11 billion by 2034, exhibiting a CAGR of 10.71%... Read More
The global open rotor engine market size is projected to grow from $360.9 million in 2026 to $2,205.8 million by 2034, exhibiting a CAGR of 25.4%... Read More
The global fuselage market size is projected to grow from $26.12 billion in 2026 to $43.01 billion by 2034, exhibiting a CAGR of 6.4% during the forecast period... Read More
The global aircraft oxygen mask market size is projected to grow from $2,597.1 million in 2026 to $3,934.3 million by 2034, exhibiting a CAGR of 5.3%... Read More
The global integrated modular avionics market size is projected to grow from $5.91 billion in 2026 to $9.58 billion by 2034, exhibiting a CAGR of 6.22%... Read More
The global aircraft fuel nozzle market size is projected to grow from $1.36 billion in 2026 to $3.38 billion by 2034, at CAGR of 12.02% during the forecast period... Read More
The composite sandwich panel market size is projected to grow from $8.72 billion in 2026 to $14.96 billion by 2034, exhibiting a CAGR of 7.0%... Read More
The global business jet MRO market size is projected to grow from $21.98 billion in 2026 to $39.41 billion by 2034, exhibiting a CAGR of 7.57%... Read More
industries.healthcare.healthcare_infrastructure.description
The primary objective of epidemiology reports is to provide data-driven insights into the incidence, prevalence, and distribution of diseases across different populations, geographies and time periods. These reports can play a crucial role in the assessment of market potential based on patient populations and drive the strategies for the development for healthcare products such as pharmaceuticals, medical devices, or diagnostics. Epidemiology reports include segmentation by age, gender, region, and disease stage, enabling companies to make informed decisions about market entry, product positioning, and clinical trial planning.
Assist in the estimation of the potential/addressable market based on patient population
Provide an understanding of the trend in patient population
Provide an overview of the cost of care & therapeutics market
Provide an understanding of the disease landscape
Provide an understanding of the treated patient population
We can check the feasibility of adding specific countries to the geographic scope based on your requirements.
USA
UK
Germany
France
Italy
Spain
Japan
China
India
AustraliaGlobally, chronic diseases account for almost three-quarters of all deaths. At present, more than one in three adults have at least one chronic condition. Unhealthy lifestyle and ageing population are some of the main factors contributing to the growing burden of non-communicable diseases such as diabetes and cardiovascular conditions.
Management of chronic diseases and treatment of conditions due to these chronic diseases accounts for a significantly large proportion of the total healthcare spending of all countries, developed as well as
In the U.S., around 90% of the annual healthcare spending is on people suffering from chronic and mental conditions.
The World Economic Forum estimates that the global cost of treating chronic diseases will be around USD 30 trillion by 2030.
| DISEASE INDICATION |
U.S | U.K | Germany | France | Italy | Spain | Saudi Arabia | United Arab Emirates |
|---|---|---|---|---|---|---|---|---|
| Diabetes | 32.5 | 4.0 | 6.2 | 4.0 | 4.5 | 5.2 | 4.4 | 1.0 |
| Hypertension | 148.2 | 23.2 | 30.7 | 22.2 | 25.3 | 15.7 | 15.2 | 5.3 |
| Kidney Stone | 0.67 | 0.30 | 0.38 | 0.29 | 0.26 | 0.27 | 0.13 | 0.03 |
| Obesity | 109.3 | 23.6 | 21.3 | 13.6 | 10.4 | 10.3 | 10.1 | 3.9 |
Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. If it is not treated, cancer can invade surrounding tissues and spread to other parts of the body.
Around 20 million new cancer cases are diagnosed every year with men accounting for roughly 51% of them. China, India, USA and Japan account for around 4% of new cancer cases globally.
| Type | Cancer Incidence |
|---|---|
| Trachea, Bronchus & Lung | 2.5 |
| Breast | 2.3 |
| Colorectum | 1.9 |
| Prostate | 1.5 |
| Stomach | 0.97 |
| Liver | 0.87 |
| Thyroid | 0.82 |
| Cervix Uteri | 0.66 |
| Bladder | 0.61 |
| Non-Hodgkin Lymphoma | 0.55 |
Lung Cancer, Breast Cancer, Colorectal Cancer and Prostate Cancer account for around 44% of the new cancer cases (excluding non-melanoma skin cancer).
Diabetes is a chronic medical condition in which the body either doesn't produce enough insulin or can't effectively use the insulin it produces, leading to elevated levels of glucose in the blood. Over time, high blood sugar can cause serious damage to the heart, kidneys, eyes, and nerves.
Around 540 million people suffer from diabetes globally with more than 40% of the cases undiagnosed.
The two main types of diabetes are Type 1 and Type2. Type 1 is an autoimmune condition where the body destroys insulin-producing cells, requiring lifelong insulin therapy whereas Type 2 is a metabolic disorder where the body either doesn't produce enough insulin or cells become resistant to its effects. Type 2 accounts for around 96% of the prevalent diabetes cases.
Type 1
12,504,087 (4.4%)Type 2
269,376,970 (95.6%)0–19 yrs
579,27620–44 yrs
46,553,35345–64 yrs
91,116,784>64 yrs
143,631,644Men
146,030,908 (51.8%)Women
135,850,149 (48.2%)Conditions that impair the function of the kidneys, which are responsible for filtering waste and excess fluids from the blood, are known as kidney diseases. These diseases can range from acute kidney injury to chronic kidney disease (CKD), which may progress to kidney failure if not managed properly. Common causes include diabetes, high blood pressure, infections, and genetic disorders.
Globally, around 700 million people are estimated to be suffering from chronic kidney disease (CKD). Around 14% of adults in the U.S. are estimated to have CKD. Kidney diseases account for almost 2-4% of the total healthcare budgets in many developed nations. In the U.S., the annual cost of kidney diseases is estimated to be more than USD 85 billion.
Around 2 million people worldwide suffer from end-stage renal disease (ESRD), for which they receive dialysis or kidney transplants.
|
USA
|
750,000 |
|
Japan
|
350,000 |
|
Brazil
|
200,000 |
|
Germany
|
80,000 |
|
UK
|
70,000 |
A condition affecting less than 65 per 100,000 people is defined as a rare disease by the WHO. The global prevalence of more than 7,000 rare diseases together is around 300 million. More than 65% of the patients suffering from rare diseases are children and majority of these diseases do not have any treatment.
| Cystic Fibrosis | Lou Gehrig's Disease (ALS) | Huntington's Disease | Duchenne Muscular Dystrophy (DMD) |
|---|---|---|---|
| 40,000 | 18,000 | 30,000 | 15,000 |
Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels, including conditions like coronary artery disease, heart failure, stroke, and hypertension. They are the leading cause of death globally, often resulting from a combination of lifestyle factors and underlying health conditions.
It is estimated that around 60% of the U.S. adults will have some form of cardiovascular disease (CVD) in the next 30 years and the cost (direct and indirect) of CVD will be around USD 1.8 trillion. Globally, around 700 million people are living with CVDs and CVDs account for around one in three deaths every year.
Download Sample
Buy Now